tykhr
sign in
free sign up
Supernus Pharmaceuticals Inc
Drug Manufacturers - Specialty & Generic
Healthcare
SUPN
56.02 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
30.00
52 week high
40.00
high
32.05
52 week low
25.77
low
29.77
growth
17.11 %
previous Close
30.64
P/E ratio
market cap
2.05 B
div yield
0
usd
Sep 2024
qoq
revenue
176 M
4.37 %
net incoming
38.50 M
93.30 %
eps
0.00 %
91.67 %
eps surprise
56.82 %
net profit margin
21.91 %
10.00 %
operating incoming
40.85 M
124.25 %
net change in cash
-20.42 M
-80.48 %
cash on hand
31.67 M
-39.19 %
cost of revenue
37.67 M
-2.47 %
top